Read the full MIT News article here. Images from AIM were also featured as the spotlight story (main image) of MIT's homepage for August 17th 2015.
AIM Biotech is making available its first 3D cell culture device, DAX-1, to R&D customers around the world. Designed as an easy-to-use, modular platform, the chip enables cell biologists to develop biological models incorporating 3D structures such as microvasculature and cancer cell spheroids. The core technology was developed by Professor Roger D. Kamm et al. at the Massachusetts Institute of Technology (MIT) & the Singapore-MIT Alliance for Research & Technology (SMART), and has been used in angiogenesis, metastatic cancer, neuroscience and stem cell research. AIM Biotech has made the technology accessible to researchers by designing the products to work in typical cell biology laboratories. Learn more at www.aimbiotech.com.